Medical research news covering clinical trials, drug development, treatment breakthroughs, and advances in medical science.
A clinical trial involving three patients with drug-resistant epilepsy showed that an experimental gene therapy reduced monthly seizures by more than 90%. The treatment uses an engineered virus to deliver a gene allowing neurons to bind with clozapine, enabling dose adjustment. Seizures resumed for one patient who stopped taking the medication but ceased upon resuming it.
Research presented at the American Heart Association's Scientific Sessions found a strong association between caffeinated energy drinks and cardiac issues in adults aged 18 to 34. Cardiologist Sarah Alexander discussed when consumption becomes hazardous, as sales have doubled over the past decade alongside rising reported cardiac issues.
The article reports on scientific advancements where researchers are engineering cancer cells to produce destructive chemicals internally. It suggests this approach could replace systemic drug flooding, offering a more targeted treatment method for tumors while potentially reducing side effects associated with traditional chemotherapy.
Hong Kong University of Science and Technology president Nancy Ip received the Unesco-Equatorial Guinea International Prize in Paris on Friday. She was recognized for her work discovering biomarkers and creating blood tests that enable earlier diagnosis and monitoring of Alzheimer's disease.
The National reports on the Zayed Centre for Research into Rare Disease in Children's advancements in regenerative medicine, specifically Prof Paolo De Coppi's work on developing mini-organs for implantation. The article highlights the centre's multidisciplinary approach, combining stem-cell biology, bioengineering, and surgical expertise to create personalized organ grafts for children.
Rush University Medical Center surgeons completed the third successful implantation of the ICVP device, which offers artificial vision to patients with total blindness. The wireless system stimulates the visual cortex to enable basic visually guided tasks, marking progress in an ongoing preclinical trial.
Kirk Leech argues that public engagement is essential to counter activist campaigns against nonhuman primate research in Europe. He contends that transparency helps maintain support for vital biomedical studies, citing Dutch legislative reversals and German political defenses as evidence of the need to combat misinformation about animal testing.
Philanthropist Steve Pagliuca is funding a $15 million research effort through the PolyBio Research Foundation to develop diagnostic tests and treatments for long COVID. The initiative targets the estimated 18 million U.S. adults affected, focusing on detecting persistent viral traces in tissues that may drive chronic inflammation.
Dr. Keith Roach contends that next-generation genetic sequencing (NGS) can significantly reshape cancer treatment plans for specific malignancies like lung and prostate cancers. He suggests that while NGS offers precision therapy benefits, it is not universally appropriate due to high costs, time delays, and the need for patients to be healthy enough to tolerate resulting treatments.
New research analyzing data from nearly half a million Americans finds that occasional cannabis consumption is associated with a 23% higher risk of cardiovascular disease and stroke. Study authors note the link applies to both low and heavy users, though no significant connection was found specifically with heart attacks.